Clinical Trial Update: Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity [Phase 1]

View source ↗

Summary

Sanofi conducted a Phase I randomized, placebo-controlled, double-blind, dose-ranging study in Clostridioides difficile infection and diarrhea to assess safety,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Diarrhea
• Clostridioides Difficile Infection

Snippet

Sponsor: Sanofi | Conditions: Clostridium Difficile Infection, Clostridium Difficile Diarrhea | Phase 1 | Status: TERMINATED | Results posted: 2012-05-21